A study found that children with early-onset atopic dermatitis have a higher risk of developing uveitis and should be closely ...

Katrina Ronne shares her vision to empower ophthalmologists, champion equity, and strengthen advocacy for better eye health ...

Although it improved interdisciplinary communication, ongoing review and safety monitoring are necessary for successful ...

Alumis and Acelyrin have filed a definitive proxy statement/prospectus with the US Securities and Exchange Commission for the ...

Nordic Pharma plans to announce commercialization details in the near future for the dry eye disease treatment ...

In celebration of Ophthalmology Times 50th anniversary, we asked leading experts in the field what they see as the biggest innovation in ophthalmology in the last 5 decades.

The trial is designed to assess the safety and effectiveness of Avisi Technologies' investigational VisiPlate device in ...

The decision to discontinue the trials comes shortly after the announcement that COAST missed its primary endpoint.

Labtician Ophthalmics has announced the commercial launch of Lab TRIACTIV, an artificial tear designed to redefine dry eye ...

The company stated that the FDA noted at least one additional adequate and well controlled study to demonstrate a positive ...

Andrew G. Lee, MD, and Drew Carey, MD, return for this episode of 'NeuroOp Guru' to discuss how sixth nerve palsy with ...